Zydus gets nod for H1N1 vaccine studies in India
This article was originally published in Scrip
Executive Summary
A potential Indian vaccine for H1N1 influenza appears to be on the horizon, following approval from the Drugs Controller General of India for the start of clinical trials with a vaccine from the domestic company, Zydus Cadila.